Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-330-3 | CAS number: 2416-94-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The substance has been identified as skin sensitizer in the Local Lymph Node Assay.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2009-08-19 to 2009-11-11
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 2002-04-24
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- cited as Commission Regulation (EC) No 440/2008, 2008-05-30
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Version / remarks:
- March 2003
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
female CBA/J mice
- Source: Charles River Laboratories, Research Models and Services, Germany GmbH, Sandhofer Weg 7, 97633 Sulzfeld
- Age at study initiation: 8 - 12 weeks
- Weight at study initiation: 18.3 - 21.9 g
- Housing: single housing in Makrolon cages, type II
- Diet: Kliba-Labordiät (Maus / Ratte Haltung “GLP”), Provimi Kliba SA, Kaiseraugst, Basel, Switzerland, ad libitum
- Water: tap water ad libitum
- Acclimation period: 14 days before the first test-item application
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24 °C
- Humidity (%): 30 - 70 %
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 2009-08-19 (arrival of the animals at the testing facility) To: 2009-09-07 (sacrifice) - Vehicle:
- methyl ethyl ketone
- Remarks:
- (MEK)
- Concentration:
- 10, 30, 60% (w/w)
- No. of animals per dose:
- 5 females per group
- Details on study design:
- RANGE FINDING TESTS:
- The selection of concentrations took into account available information on the chemical/physical properties, the composition and on acute toxicity and primary irritation/corrosion potential of the test item. In addition the results of a pretest with a 60% test-item preparation were considered, which did not show increased ear weights, but increased lymph node weights as indication of ear irritation. Due to the chemical/physical properties of the test substance (melt), higher concentrations could not be applied technically.
- The following dose levels were selected: 10%, 30% and 60% in methyl ethyl ketone (MEK). A vehicle control group was included.
MEK was used as the vehicle because good solubility of the preparation was achieved.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Criteria used to consider a positive response:
In order to reveal a possible induction of sensitization, the response in the draining lymph node after epicutaneous application of several concentrations of the test substance to the skin of the ear backs is determined. The parameters used to characterize the response are lymph node cell count, ³H-thymidine incorporation into the lymph node cells and to a certain extent lymph node weight. Because not only sensitization induction but also irritation of the ear skin by the test substance may induce lymph node responses, the weight of ear punches taken from the area of test-substance application is determined as a parameter for inflammatory ear swelling serving as an indicator for the irritant action of the test substance.
The increase SI of cell count by a factor of ≥ 1.5 and/or of ³H-thymidine incorporation by a factor of ≥ 3 as compared to the concurrent vehicle control group is generally considered as indicating a sensitizing potential of a test substance.
If applicable, the EC (estimated concentration) leading to the respective SI values were calculated by linear or semi-logarithmical regression between the data points directly below and above the SI if possible or using the two nearest points below or above the SI.
In addition the evaluation uses the following considerations:
If biologically relevant increases in ear weights are running in parallel to the increase in cell count, ³H-thymidine incorporation and/or lymph node weight, it cannot be ruled out, that the lymph node response was caused by irritation and not by skin sensitization. Depending on the magnitude of lymph node response the evaluation of the sensitizing potential may be modified or additional studies might be necessary.
If a test substance does not elicit a biological relevant increase in cell count, ³H-thymidine incorporation but shows a clear concentration related increase in response, further investigation of the sensitization potential at higher concentrations should be considered.
TREATMENT PREPARATION AND ADMINISTRATION:
For better handling the test item was heated at ca. 80°C before test-item preparation. The test-item preparations were produced on a weight per weight basis shortly before the application. After stirring with a magnetic stirrer the test item was soluble in the vehicle.
The study used 4 groups of 5 female CBA/J mice each (3 test groups and 1 control group). The mice were treated with 10%, 30% and 60% (w/w) preparations of the test substance in MEK (methyl ethyl ketone) or with the vehicle alone. The 60% preparation was the maximum technically applicable concentration.
Each test animal was applied with 25 µL per ear of the respective test-substance preparation to the dorsum of both ears for three consecutive days. The control group was treated with 25 µL per ear of the vehicle alone. Three days after the last application the mice were injected intravenously with 20 µCi of ³H-thymidine in 250 µL of sterile saline into a tail vein. About 5 hours after the ³H-thymidine injection, the mice were sacrificed and the auricular lymph nodes were removed. The weights of each animal’s pooled lymph nodes were determined. Thereafter lymph nodes were pooled group wise and further evaluated by measuring their cellular content and ³H-thymidine incorporation into the lymph node cells (indicators of cell proliferation). Moreover, a defined area with a diameter of 0.8 cm (ca. 50 mm²) was punched out of the apical part of each ear and for each test group the weight of the pooled punches was determined in order to obtain an indication of possible skin irritation.
Calculations:
The stimulation indices of cell count, ³H-thymidine incorporation, lymph node weight and ear weight were calculated as the ratio of the test group values for these parameters divided by those of the vehicle control group.
Further examinations:
Body weight determination:
Individual body weights on day 0 prior to the first application and on day 5 prior to the sacrifice of the animals.
Signs and symptoms:
No detailed clinical examination of the individual animals was performed but any obvious signs of systemic toxicity and/or local inflammation at the application sites were noted.
Mortality:
Twice each workday (beginning and end) and once on Saturdays, Sundays and on public holidays.
Positive control:
A concurrent positive control (reliability check) with a known sensitizer was not included into this study. Separate studies using the positive control substance alpha-hexylcinnamaldehyde are performed twice a year in the laboratory in order to show that the test system is able to detect sensitizing compounds under the test conditions chosen. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- no data
- Positive control results:
- Positive control study: Alpha-Hexylcinnamaldehyde, techn. 85%; Group mean values: Cell Counts/ Lymph Node Pair: 14,832,000; ³H-thymidine
incorporation [DPM/Lymph Node Pair]: 2,270.5; Lymph Node Weight [mg//Lymph Node Pair]; Ear Weight [mg/animal].
see attached file - Parameter:
- SI
- Remarks on result:
- other: SI values calculated for ³H-TdR incorporation: vehicle control: 1.00 10% in MEK: 1.11 30% in MEK: 2.34 60% in MEK: 3.62 For other stimulation indices, see freetext in "Remarks on results including tables and figures", table 2.
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: ³H-thymidine incorporation [DPM/Lymph Node Pair] vehicle control: 702.6 10% in MEK: 777.9 30% in MEK: 1647.3 60% in MEK: 2542.2 see also attached file.
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information
- Conclusions:
- Based on the results of this test, it is concluded that 2,3,6-trimethylphenol shows a skin sensitizing effect in the Murine Local Lymph Node Assay under the test conditions chosen.
Reference
The stimulation indices (fold of change as compared to the vehicle control) for cell count, ³H-thymidine incorporation, lymph node weight and ear weight are summarized for each test group in table 2.
Table 2: Simulation indices
Test group |
Treatment |
Cell Count Stimulation Index |
³H-thymidine incorporation Stimulation Index |
Lymph Node Weight Stimulation Index |
Ear Weight Stimulation Index |
1 |
vehicle MEK |
1.00 |
1.00 |
1.00 |
1.00 |
2 |
10% in MEK |
1.04 |
1.11 |
1.10 |
1.00 |
3 |
30% in MEK |
1.26 |
2.34 |
1.27 |
1.04 |
4 |
60% in MEK |
1.83 |
3.62 |
1.62 |
1.15 |
No signs of systemic toxicity were noticed.
When applied as 60% preparation in MEK, the test item induced a biologically relevant response (increase to 1.5 fold or above of control value = stimulation index (SI) ≥ 1.5) in the auricular lymph node cell counts.
There was an increase in lymph node weights, as well.
Concomitantly, the increase of 3H-thymidine incorporation into the cells was biologically relevant (increase above the cut off stimulation index of 3) at this concentration.
The 60% test-item preparation caused some increase in ear weights as indication of ear skin irritation, the magnitude of which, however, does not fully explain the measured lymph node reactions.
The increases in cell count,3H-thymidine incorporation, lymph node weight and ear weight were concentration dependent.
Conclusion:
The authors concluded that 2,3,6-Trimethylphenol shows a skin sensitizing effect in the Murine Local Lymph Node Assay under the test conditions chosen.
The threshold concentration for sensitization induction was >30%<60%. The estimated concentration that leads to the SI of 1.5 for cell count (EC 1.5) and the estimated concentration that leads to the SI of 3.0 for 3H-thymidine incorporation (EC 3) was calculated by linear regression from the results of the 30% and 60% concentrations to be 42.6% and 45.4%, respectively.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
In a dermal sensitization study (BASF SE, 2009) with 2,3,6 -trimethylphenol (99.8% pure) in methyl ethyl ketone, young adult CBA/J mice (5 females per group) were tested using the method of the Local Lymph Node Assay (LLNA). The test substance was applied at concentrations of 10, 30, and 60% (w/w); a vehicle control group was included. The vehicle was methyl ethyl ketone (MEK). Separate studies using the positive control substance α-hexylcinnamaldehyde are routinely carried out twice a year in the performing laboratory. The study was carried out in accordance with OECD TG 429.
No signs of systemic toxicity were noticed. When applied as 60% preparation in MEK, the test item induced a biologically relevant response (increase to 1.5 fold or above of control value = stimulation index (SI) ≥ 1.5) in the auricular lymph node cell counts. There was an increase in lymph node weights, as well. Concomitantly, the increase of ³H-thymidine incorporation into the cells was biologically relevant (increase above the cut off stimulation index of 3) at this concentration. The 60% test-item preparation caused some increase in ear weights as indication of ear skin irritation, the magnitude of which, however, does not fully explain the measured lymph node reactions. The increases in cell count, ³H-thymidine incorporation, lymph node weight and ear weight were concentration dependent.
Thus, the authors concluded that 2,3,6 -trimethylphenol shows a skin sensitizing effect in the Murine Local Lymph Node Assay under the test conditions chosen. The threshold concentration for sensitization induction was >30% <60%. The estimated concentration that leads to the SI of 1.5 for cell count (EC 1.5) and the estimated concentration that leads to the SI of 3.0 for ³H-thymidine incorporation (EC 3) was calculated by linear regression from the results of the 30% and 60% concentrations to be 42.6% and 45.4%, respectively.
In this study, 2,3,6 -trimethylphenol is a dermal sensitizer.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the results of the Local Lymph Node Assay, 2,3,6 -Trimethylphenol has to be classified as skin sensitizer Cat. 1B (H317) according to the EU Classification, Labelling, and Packaging of Substances and Mixtures (CLP) Regulation N. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.